Person

Richard S. Levy

Formerly EVP, Chief Drug Dev Officer, Incyte

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$401K

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • INCY
    Incyte
    EVP, Chief Drug Dev Officer
    2016 or earlier – last filing Jan 2016

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jan 6, 2016INCYSale3,937$101.86$401K

SEC reporting-owner ID (CIK) 1454983 · all filings on EDGAR